Repare Therapeutics Inc (RPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 1,073 | 52,404 | 13,047 | 2,159 | 30,249 |
| Gross Profit | 1,073 | 52,404 | 13,047 | 2,159 | 30,249 |
| Operating Expenses | 38,392 | 41,588 | 43,914 | 40,577 | 42,507 |
| Operating Income | -37,319 | 10,816 | -30,867 | -38,418 | -12,258 |
| Other Income | 2,871 | 2,975 | 3,027 | 3,240 | 3,422 |
| Pre-tax Income | -34,448 | 13,791 | -27,840 | -35,178 | -8,836 |
| Income Tax | 326 | 629 | 190 | -16,299 | 3,110 |
| Net Income Continuous | -34,774 | 13,162 | -28,030 | -18,879 | -11,946 |
| Net Income | $-34,774 | $13,162 | $-28,030 | $-18,879 | $-11,946 |
| EPS Basic Total Ops | -0.82 | 0.31 | -0.67 | -0.45 | -0.28 |
| EPS Basic Continuous Ops | -0.82 | 0.31 | -0.67 | -0.45 | -0.28 |
| EPS Diluted Total Ops | -0.82 | 0.30 | -0.67 | -0.45 | -0.28 |
| EPS Diluted Continuous Ops | -0.82 | 0.30 | -0.67 | -0.45 | -0.28 |
| EPS Diluted Before Non-Recurring Items | -0.82 | 0.30 | -0.67 | N/A | N/A |
| EBITDA(a) | $-38,494 | $10,072 | $-32,017 | $-39,801 | $-13,841 |